Titan Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DRW SECURITIES, LLC | 11/14/2025 | 21.27 K | $101.87 K | 100.00% | 2.00% |
| UBS GROUP AG | 11/13/2025 | 480 | $2.30 K | -85.99% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 469 | $2.25 K | 100.00% | 0.04% |
| CORECAP ADVISORS, LLC | 10/22/2025 | 88 | $422 | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 19 | $91 | 5.56% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 12 | $58 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 10 | $35 | 0.00% | 0.00% |
| BLACKROCK, INC. | 11/12/2025 | 6 | $29 | 0.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 2 | $10 | 0.00% | 0.00% |
| GLOBAL WEALTH STRATEGIES & ASSOCIATES | 10/02/2025 | 2 | $10 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 1 | $5 | 0.00% | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 10/29/2025 | 1 | $5 | 0.00% | 0.00% |
| ST GERMAIN D J CO INC | 10/07/2025 | 1 | $5 | 0.00% | 0.00% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 11/04/2025 | 1 | $5 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 1 | $5 | 0.00% | 0.00% |
| NEMES RUSH GROUP LLC | 11/13/2025 | 1 | $5 | 0.00% | 0.00% |
| RANSOM ADVISORY, LTD | 10/07/2025 | 1 | $5 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MAREX GROUP PLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Titan Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Titan Pharmaceuticals, Inc.. The most heavily invested institutionals were:
DRW Securities, LLC: 21,267
UBS Group AG: 480
Tower Research Capital LLC (TRC): 469
CoreCap Advisors, LLC: 88
BANK OF AMERICA CORP /DE/: 19
GROUP ONE TRADING, L.P.: 12
2.10% of Titan Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 22.39 K shares in the last 24 months. This purchase volume represents approximately $102.30 K in transactions.